Cloned (Comment) | Organism |
---|---|
expressed in Pichia pastoris strain X33 | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
hanging drop vapor diffusion method, using 100 mM imidazole (pH 8.0), 30% (v/v) 2-methyl-2,4-pentanediol, and 11% (w/v) 4000 PEG | Homo sapiens |
hanging drop vapor diffusion method, using 100 mM sodium acetate (pH 5.3), 200 mM ammonium sulfate, and 12% (w/v) 2000 MME-PEG | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
W207F | the mutation alters substrate conversion significantly, while the binding constants of inhibitors such as the highly potent PBD150 are minimally affected | Homo sapiens |
W207L | the mutation alters substrate conversion significantly, while the binding constants of inhibitors such as the highly potent PBD150 are minimally affected | Homo sapiens |
W207Q | the mutation alters substrate conversion significantly, while the binding constants of inhibitors such as the highly potent PBD150 are minimally affected | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-Methylimidazole | - |
Homo sapiens | |
1-Methylimidazole | - |
Mus musculus | |
benzimidazole | - |
Homo sapiens | |
benzimidazole | - |
Mus musculus | |
benzylimidazole | - |
Homo sapiens | |
benzylimidazole | - |
Mus musculus | |
cysteamine | - |
Homo sapiens | |
cysteamine | - |
Mus musculus | |
imidazole | - |
Homo sapiens | |
imidazole | - |
Mus musculus | |
Nomega-acetylhistamine | - |
Homo sapiens | |
Nomega-acetylhistamine | - |
Mus musculus | |
PBD150 | highly potent inhibitor | Homo sapiens | |
PBD150 | highly potent inhibitor | Mus musculus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | the enzyme contains a catalytic zinc ion | Homo sapiens | |
Zn2+ | the enzyme contains a catalytic zinc ion | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q16769 | - |
- |
Mus musculus | Q9CYK2 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | - |
Homo sapiens |
glycoprotein | - |
Mus musculus |
Purification (Comment) | Organism |
---|---|
- |
Mus musculus |
chelating Sepharose column chromatography and butyl Sepharose column chromatography | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-Gln-2-naphthylamide | - |
Homo sapiens | 5-oxoprolyl-2-naphthylamide + NH3 | - |
? | |
L-Gln-2-naphthylamide | - |
Mus musculus | 5-oxoprolyl-2-naphthylamide + NH3 | - |
? | |
L-Gln-7-amido-4-methylcoumarin | - |
Homo sapiens | 5-oxoprolyl-7-amido-4-methylcoumarin + NH3 | - |
? | |
L-Gln-7-amido-4-methylcoumarin | - |
Mus musculus | 5-oxoprolyl-7-amido-4-methylcoumarin + NH3 | - |
? | |
L-Gln-Gly-L-Pro | - |
Homo sapiens | 5-oxoprolyl-Gly-L-Pro + NH3 | - |
? | |
L-Gln-Gly-L-Pro | - |
Mus musculus | 5-oxoprolyl-Gly-L-Pro + NH3 | - |
? | |
L-Gln-L-Gln | - |
Homo sapiens | 5-oxoprolyl-L-Gln + NH3 | - |
? | |
L-Gln-L-Gln-OH | - |
Mus musculus | 5-oxoprolyl-L-Gln + NH3 | - |
? | |
L-Gln-L-Glu | - |
Homo sapiens | 5-oxoprolyl-L-Glu + NH3 | - |
? | |
L-Gln-L-Glu-L-Asp-L-Leu-NH2 | - |
Homo sapiens | 5-oxoprolyl-L-Glu-L-Asp-L-Leu-NH2 + NH3 | - |
? | |
L-Gln-L-Glu-L-Asp-L-Leu-NH2 | - |
Mus musculus | 5-oxoprolyl-L-Glu-L-Asp-L-Leu-NH2 + NH3 | - |
? | |
L-Gln-L-Glu-OH | - |
Mus musculus | 5-oxoprolyl-L-Glu + NH3 | - |
? | |
L-Gln-L-Phe-L-Ala-NH2 | - |
Homo sapiens | 5-oxoprolyl-L-Phe-L-Ala-NH2 + NH3 | - |
? | |
L-Gln-L-Phe-L-Ala-NH2 | - |
Mus musculus | 5-oxoprolyl-L-Phe-L-Ala-NH2 + NH3 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
glutaminyl cyclase | - |
Homo sapiens |
glutaminyl cyclase | - |
Mus musculus |